Literature DB >> 348031

Polymyalgia rheumatica and giant cell arteritis.

R E Ettlinger, G G Hunder, L E Ward.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 348031     DOI: 10.1146/annurev.me.29.020178.000311

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


× No keyword cloud information.
  8 in total

1.  Giant Cell Arteritis.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

2.  The influence of sectional interval on the reliability of temporal arterial biopsies in polymyalgia rheumatica.

Authors:  E Nordborg; C Nordborg
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

3.  Pulmonary function of nonsmoking patients with giant cell arteritis and/or polymyalgia rheumatica; a controlled study.

Authors:  N C Acritidis; A P Andonopoulos; V Galanopoulou; A A Drosos; S H Constantopoulos
Journal:  Clin Rheumatol       Date:  1988-06       Impact factor: 2.980

4.  Temporal artery biopsy and corticosteroid treatment.

Authors:  M C Allison; P J Gallagher
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

5.  Heberden Society: combined meeting, July 1979.

Authors: 
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

6.  Histological parameters helpful in recognising steroid-treated temporal arteritis: an analysis of 35 cases.

Authors:  Ramon L Font; Venkatesh C Prabhakaran
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

7.  Immune complexes, rheumatoid factors, and cellular immunological parameters in patients with giant cell arteritis.

Authors:  B E Malmvall; B A Bengtsson; L A Nilsson; L M Bjursten
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

8.  Prognosis and management of polymyalgia rheumatica.

Authors:  J G Jones; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.